$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 17, 2025)
$25.25B
Market Cap
15.63
P/E Ratio
11.01
EPS
$185.17
52 Week High
$110.04
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - GENERAL
Biogen Inc. is a prominent biotechnology company headquartered in Cambridge, Massachusetts, specializing in the discovery and development of groundbreaking therapies for neurological disorders. With an extensive pipeline targeting significant conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, Biogen is positioned as a critical player in addressing substantial unmet medical needs in the healthcare landscape. The company's focus on advancing therapeutic innovation is complemented by strategic collaborations and a strong commitment to scientific research, underscoring its leadership within the biotechnology sector and dedication to enhancing patient outcomes globally.
LPTX
NVDA
IRBT
TSLA
CGC
PLUG
WOK
AVGO
GRAB
WBD
ASST
RXRX
SNAP
RZLV
PFE
F
AAL
PLTD
INTC
BITF
ADAP
NFLX
PLTR
ORCL
SOFI
MARA
LAZR
CIFR
WULF
GOOGL
BYND
MU
DNN
ADTX
T
PCSA
IVP
KVUE
HOOD
RIG
BAC
RGTI
IREN
AMD
HPE
VHAI
TLRY
ITUB
QBTS
APLD
BTBT
GOOG
NIO
CPNG
VICI
UBER
CMG
CLSK
CSCO
AG
VALE
SMCI
MSFT
PBR
AMC
HBAN
RKLB
QS
PCG
LPTX
NVDA
IRBT
TSLA
CGC
PLUG
WOK
AVGO
GRAB
WBD
ASST
RXRX
SNAP
RZLV
PFE
F
AAL
PLTD
INTC
BITF
ADAP
NFLX
PLTR
ORCL
SOFI
MARA
LAZR
CIFR
WULF
GOOGL
BYND
MU
DNN
ADTX
T
PCSA
IVP
KVUE
HOOD
RIG
BAC
RGTI
IREN
AMD
HPE
VHAI
TLRY
ITUB
QBTS
APLD
BTBT
GOOG
NIO
CPNG
VICI
UBER
CMG
CLSK
CSCO
AG
VALE
SMCI
MSFT
PBR
AMC
HBAN
RKLB
QS
PCG